Authentication support apparatus, system, method, and program

Abstract

To reduce inconvenience of three-factor authentication before administration of a medication to a patient.SOLUTION: An authentication support apparatus includes: first acquisition means for acquiring a wearer authentication result indicating whether or not a wearer is a predetermined medical practitioner on the basis of an iris authentication result of the wearer who is wearing an eyewear-type wearable terminal; second acquisition means for acquiring a patient authentication result based on authentication information of a patient imaged by the eyewear-type wearable terminal; third acquisition means for acquiring medication registration information indicating a correspondence between a medication identified on the basis of medication information of the medication imaged by the eyewear-type wearable terminal and the patient who is an administration target; and output control means for causing a wearer screen of the eyewear-type wearable terminal to display a three-factor authentication result regarding permissibility of medical practice of administering the medication to the patient by the wearer on the basis of the wearer authentication result, the patient authentication result, and the medication registration information.SELECTED DRAWING: Figure 1

Description

[Technical Field]

[0001] The present disclosure relates to an authentication support device, a system, a method, and a program. [Background technology]

[0002] In the case of a medical procedure involving administering medication to a patient, the person intending to perform the medical procedure (prospective medical practitioner) performs the so-called "three-point authentication" consisting of the following steps (1) to (3) before administering the medication. Here, "three-point authentication" refers to the authentication of three points: (1) authentication that the prospective medical practitioner is qualified to perform medical procedures, (2) authentication of the patient's identity, and (3) authentication that the patient authenticated in (2) is the intended recipient of the medication (type of medication, dosage, medication identification information, etc.). The prospective medical practitioner is then required to administer the medication to the patient only after confirming the three-point authentication. The prospective medical practitioner is also required to record the results of the three-point authentication.

[0003] Patent Document 1 discloses technology related to a medical practice judgment system. The system in Patent Document 1 photographs a nurse with a camera, performs facial recognition, and uses the facial recognition results, a patient-side judgment device, and a drug-side judgment device to comprehensively judge whether the correspondence between the nurse, patient, and drug is correct. [Prior art documents] [Patent documents]

[0004] [Patent Document 1] Japanese Patent Application Laid-Open No. 2005-062994 Summary of the Invention [Problem to be solved by the invention]

[0005] However, there is a problem in that it is cumbersome for a medical practitioner to perform three-point authentication before administering medicine to a patient. In particular, in an emergency, the cumbersomeness of three-point authentication may increase the risk of medical accidents.

[0006] In view of the above-mentioned problems, an object of the present disclosure is to provide an authentication support device, system, method, and program for reducing the complexity of three-point authentication before administering medication to a patient. [Means for solving the problem]

[0007] An authentication support device according to the present disclosure includes: a first acquisition means for acquiring a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on an iris authentication result of the wearer while wearing the glasses-type wearable terminal; a second acquisition means for acquiring a patient authentication result based on the patient's authentication information photographed by the glasses-type wearable terminal; a third acquisition means for acquiring drug registration information indicating a correspondence between a drug identified based on drug information of the drug photographed by the glasses-type wearable terminal and a patient to be administered the drug; an output control means for displaying a three-point authentication result regarding whether or not the wearer can administer the drug to the patient based on the wearer authentication result, the patient authentication result, and the drug registration information on a screen for the wearer of the eyeglass-type wearable terminal; Equipped with.

[0008] The authentication support system according to the present disclosure includes: A glasses-type wearable device, an authentication support device; The glasses-type wearable terminal includes: An iris image of the wearer while wearing the device, the photographed patient authentication information, and the photographed medication information are transmitted to the authentication support device; the authentication assistance device, acquiring a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on an iris authentication result for the iris image received from the glasses-type wearable terminal; acquiring a patient authentication result based on the authentication information received from the glasses-type wearable terminal; acquiring drug registration information indicating a correspondence between the drug identified based on the drug information received from the eyeglass-type wearable terminal and a patient to whom the drug is to be administered; transmitting a three-point authentication result regarding whether or not the wearer can administer the medication to the patient based on the wearer authentication result, the patient authentication result, and the medication registration information to the glasses-type wearable terminal; The glasses-type wearable terminal includes: The three-point authentication result received from the authentication support device is displayed on a screen for the wearer.

[0009] The authentication support method according to the present disclosure includes: The computer Based on the iris authentication result of the wearer while wearing the eyeglass-type wearable device, a wearer authentication result is obtained as to whether the wearer is a predetermined medical practitioner; acquiring a patient authentication result based on the patient's authentication information photographed by the glasses-type wearable terminal; Acquire drug registration information indicating a correspondence between the drug identified based on the drug information of the drug photographed by the eyeglass-type wearable terminal and the patient to whom the drug is to be administered; Based on the wearer authentication result, the patient authentication result, and the drug registration information, the three-point authentication result regarding whether the wearer can administer the drug to the patient is displayed on the wearer's screen of the eyeglass-type wearable terminal.

[0010] The authentication support program disclosed herein is a first acquisition process for acquiring a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on the iris authentication result of the wearer while wearing the glasses-type wearable terminal; a second acquisition process for acquiring a patient authentication result based on the patient's authentication information photographed by the glasses-type wearable terminal; a third acquisition process for acquiring drug registration information indicating a correspondence between the drug identified based on the drug information of the drug photographed by the glasses-type wearable terminal and the patient to whom the drug is to be administered; an output control process for displaying a three-point authentication result regarding whether or not the wearer can administer the medication to the patient based on the wearer authentication result, the patient authentication result, and the medication registration information on a wearer screen of the eyeglass-type wearable terminal; to be executed by the computer. [Effects of the Invention]

[0011] The present disclosure can reduce the complexity of three-point authentication before administering medication to a patient. [Brief explanation of the drawings]

[0012] [Figure 1] 1 is a block diagram illustrating a configuration of an authentication support device according to the present disclosure. [Figure 2] 1 is a flowchart illustrating a flow of an authentication support method according to the present disclosure. [Figure 3] 1 is a block diagram showing the overall configuration of an authentication support system according to the present disclosure. [Figure 4] FIG. 1 is a diagram for explaining the concept of three-point authentication and drug administration performed by a medical practitioner wearing AR glasses according to the present disclosure. [Figure 5] FIG. 1 is a block diagram illustrating a configuration of AR glasses according to the present disclosure. [Figure 6] FIG. 1 is a block diagram showing the hardware configuration of AR glasses according to the present disclosure. [Figure 7] FIG. 2 is a block diagram illustrating a configuration of an authentication support server according to the present disclosure. [Figure 8] FIG. 2 is a block diagram showing a hardware configuration of an authentication support server according to the present disclosure. [Figure 9] 10 is a sequence chart showing the flow of authentication support processing when a medical professional wears AR glasses (normal mode) according to the present disclosure. [Figure 10] FIG. 10 is a diagram showing a display example of a screen for a wearer of the AR glasses when the AR glasses according to the present disclosure are worn (normal mode). [Figure 11]10 is a sequence chart showing a flow of authentication support processing at the start of three-point authentication according to the present disclosure. [Figure 12] FIG. 10 is a diagram showing a display example of a screen for a wearer of the AR glasses after a state transition to a three-point authentication execution state according to the present disclosure. [Figure 13] FIG. 10 is a diagram showing an example of a display on a screen for a wearer of AR glasses after a patient's face image and medication information according to the present disclosure are read. [Figure 14] FIG. 10 is a diagram illustrating an example of an operation for transitioning to a three-point authentication execution state according to the present disclosure. [Figure 15] FIG. 10 is a diagram illustrating an example of an operation for transitioning to a three-point authentication execution state according to the present disclosure. [Figure 16] FIG. 10 is a diagram illustrating an example of an operation for transitioning to a three-point authentication execution state according to the present disclosure. [Figure 17] FIG. 10 is a diagram showing an example of a display on a screen for a wearer of AR glasses when three-point authentication according to the present disclosure is successful. [Figure 18] FIG. 10 is a diagram showing an example of a display on a screen for a wearer of AR glasses when three-point authentication according to the present disclosure has failed. [Figure 19] FIG. 1 is a diagram for explaining the concept of three-point authentication performed by a medical practitioner wearing AR glasses according to the present disclosure. [Figure 20] FIG. 1 is a block diagram illustrating a configuration of AR glasses according to the present disclosure. DETAILED DESCRIPTION OF THE INVENTION

[0013] Hereinafter, embodiments of the present disclosure will be described in detail with reference to the drawings. In each drawing, the same or corresponding elements are designated by the same reference numerals, and for clarity of explanation, duplicate explanations will be omitted as necessary.

[0014] <Embodiment 1> FIG. 1 is a block diagram showing the configuration of an authentication support device 1. The authentication support device 1 is an information processing device that supports three-point authentication regarding whether a predetermined medical practitioner can administer a pre-registered drug to a patient. Here, a "medical practitioner" refers to a medical professional who is qualified to administer (e.g., by injection) a drug to a patient. A medical practitioner is, for example, a qualified doctor, nurse, or the like. It is assumed that the medical practitioner wears a glasses-type wearable device that is capable of iris authentication of the wearer when performing three-point authentication and administering the drug. The authentication support device 1 may be either the glasses-type wearable device itself or a computer server communicably connected to the glasses-type wearable device.

[0015] The authentication support device 1 includes a first acquisition unit 11, a second acquisition unit 12, a third acquisition unit 13, and an output control unit 14. The first acquisition unit 11 acquires a wearer authentication result indicating whether the wearer is a specified medical practitioner based on the iris authentication result of the wearer while wearing the eyeglass-type wearable terminal. The second acquisition unit 12 acquires a patient authentication result based on authentication information of the patient photographed by the eyeglass-type wearable terminal. The third acquisition unit 13 acquires drug registration information identified based on drug information of the drug photographed by the eyeglass-type wearable terminal. The drug registration information indicates the correspondence between drugs and the patients to be administered.

[0016] The output control unit 14 displays the three-point authentication result on the wearer's screen of the eyeglass-type wearable terminal based on the wearer authentication result, the patient authentication result, and the medication registration information. The three-point authentication result is an authentication result regarding whether the wearer can administer medication to a patient.

[0017] 2 is a flowchart showing the flow of the authentication support method. First, the first acquisition unit 11 acquires a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on the iris authentication result of the wearer while wearing the eyeglass-type wearable terminal (S1). Next, the second acquisition unit 12 acquires a patient authentication result based on authentication information of the patient photographed by the eyeglass-type wearable terminal (S2). Furthermore, the third acquisition unit 13 acquires drug registration information indicating the correspondence between the identified drug and the patient to be administered based on the drug information of the drug photographed by the eyeglass-type wearable terminal (S3). Note that the order of steps S1 to S3 is not limited to this. For example, two or more of steps S1 to S3 may be executed in parallel.

[0018] After steps S1 to S3, the output control unit 14 displays the three-point authentication result regarding whether the wearer can administer medication to the patient based on the wearer authentication result, patient authentication result, and medication registration information on the wearer's screen of the eyeglass-type wearable terminal (S4).

[0019] In this embodiment, (1) the iris authentication performed on the wearer (scheduled medical procedure recipient) while wearing the eyeglass-type wearable terminal serves to authenticate the wearer as a person qualified to perform a prescribed medical procedure, and the wearer's attribute information, etc., identified through the personal authentication can be used to authenticate that the wearer is qualified to perform a prescribed medical procedure. If the iris authentication information of persons qualified to perform a prescribed medical procedure is registered in the iris authentication database, the wearer's successful iris authentication can be regarded as authentication that the wearer is qualified to perform a prescribed medical procedure.

[0020] In this embodiment, (2) patient authentication is performed based on authentication information identified from an image of the patient captured by the wearer via the eyeglass-type wearable device, thereby enabling personal authentication of the patient. In this embodiment, (3) drug registration information is identified based on the drug information of the drug captured by the wearer via the eyeglass-type wearable device, allowing the identified drug registration information to be acquired. In three-point authentication, authentication is determined to be successful because (1) the wearer authentication result indicates that the prospective medical practitioner is qualified, and (3) the drug registration information acquired corresponds to the patient identified in (2) and the drug captured in (3). In this embodiment, three-point authentication is performed based on (1) to (3), and the three-point authentication result is displayed on the wearer's screen of the eyeglass-type wearable device, allowing the wearer to confirm whether or not they are qualified to administer drugs to the patient in front of them. The three-point authentication result may be registered in an external medical information system. As described above, the technology disclosed herein can reduce the complexity of three-point authentication before administering drugs to a patient.

[0021] The authentication support device 1 includes a processor, a memory, and a storage device (not shown). The storage device stores a computer program that implements the processing of the authentication support method shown in Fig. 2, for example. The processor then loads the computer program from the storage device into the memory and executes the computer program. This allows the processor to implement the functions of a first acquisition unit 11, a second acquisition unit 12, a third acquisition unit 13, and an output control unit 14.

[0022] Alternatively, each component of the authentication support device 1 may be realized by dedicated hardware. Furthermore, some or all of the components of each device may be realized by general-purpose or dedicated circuits, processors, etc., or a combination of these. These may be configured by a single chip, or by multiple chips connected via a bus. Some or all of the components of each device may be realized by a combination of the above-mentioned circuits, etc., and programs. Furthermore, a CPU (Central Processing Unit), GPU (Graphics Processing Unit), FPGA (Field-Programmable Gate Array), quantum processor (quantum computer control chip), etc., may be used as the processor.

[0023] Furthermore, when some or all of the components of the authentication support device 1 are realized by multiple information processing devices, circuits, etc., the multiple information processing devices, circuits, etc. may be centrally or distributed. For example, the information processing devices, circuits, etc. may be realized as a client-server system, a cloud computing system, etc., in a form in which each is connected via a communication network. Furthermore, the functions of the authentication support device 1 may be provided in a SaaS (Software as a Service) format.

[0024] <Embodiment 2> 3 is a block diagram showing the overall configuration of an authentication support system 1000. The authentication support system 1000 is an information system for supporting three-point authentication performed by a wearer U1 wearing AR (Augmented Reality) glasses 100 before administering a predetermined drug M to a patient U2. The authentication support system 1000 includes the AR glasses 100, an authentication support server 200, an authentication system 300, and a medical information system 400. However, it is sufficient for the authentication support system 1000 to include at least the AR glasses 100 and the authentication support server 200. The AR glasses 100, the authentication support server 200, the authentication system 300, and the medical information system 400 are communicably connected via a network N. Here, the network N is a wired or wireless communication line.

[0025] The wearer U1 is wearing the AR glasses 100 and is a person scheduled to receive medical treatment who is in the vicinity of the patient U2 and the drug M. The patient U2 is either an inpatient in a hospital bed or an outpatient. The patient U2 is scheduled to receive a specific drug from a specific medical practitioner. The drug M is a drug that is scheduled to be administered to the patient U2. The drug M is, for example, an intravenous drug, and an information code that can identify the drug information is displayed on the drug M.

[0026] The AR glasses 100 are an example of a glasses-type wearable device worn by a prospective medical practitioner for three-point authentication, and have a lens-cum-screen that transmits light from the external surrounding space. The AR glasses 100 display various display information (described later) on a screen, superimposed on a field of view in real space that transmits light from the outside and is visible to the wearer. The AR glasses 100 may be, for example, a head-mounted display (HMD). The detailed configuration of the AR glasses 100 will be described later.

[0027] The authentication support server 200 is an information processing device that supports three-point authentication using the authentication system 300, the medical information system 400, etc., in accordance with information received from the AR glasses 100. The detailed configuration of the authentication support server 200 will be described later.

[0028] The authentication system 300 is an information system that performs authentication processing to verify the identity of medical institution staff (particularly those scheduled to receive medical treatment) and patients. The authentication system 300 performs iris authentication to verify the identity of those scheduled to receive medical treatment, and facial authentication, which is a form of biometric authentication, to verify the identity of patients. Note that the authentication system 300 may also perform biometric authentication other than facial authentication or identity verification processing other than biometric authentication to verify the identity of patients. The authentication system 300 includes at least a medical institution staff DB (DataBase) 31 and a patient DB 32.

[0029] The medical institution staff DB 31 is a database for managing staff information of a specified medical institution. For example, the medical institution staff DB 31 manages staff IDs 311, iris feature information 312, and attribute information 313 in association with each other. The staff IDs 311 are identification information for staff at a specified medical institution. The iris feature information 312 is a feature vector including a collection of feature points of the irises of the staff's eyes. For example, the iris feature information 312 is a collection of information calculated as feature amounts for patterns, such as patterns, that indicate iris characteristics within an iris region detected from an image including the eyes of the relevant staff member. The attribute information 313 is information indicating the attributes of the relevant staff member, including their qualifications (for example, doctor, nurse, etc.).

[0030] The patient DB 32 is a database that manages patient IDs 321 and facial feature information 322 in association with each other. The patient DB 32 may also manage patient attribute information (such as name) other than the facial feature information 322 in association with the patient ID 321. The patient ID 321 is identification information for the patient U2. The facial feature information 322 is a feature vector including a set of facial feature points of the patient corresponding to the patient ID 321. For example, the facial feature information 322 is a set of information calculated using, as a feature amount, the distance between each feature point and the like for a plurality of feature points indicating facial features (eyes, nose, mouth, etc.) in a face region detected from a face image of the corresponding patient.

[0031] The authentication system 300 determines whether the iris authentication is successful based on the degree of match between the iris feature information (query) based on the iris image included in the iris authentication request received via the network N and multiple (master) iris feature information 312 in the medical institution staff DB 31. If the iris authentication is successful, the authentication system 300 identifies the staff ID 311 and attribute information 313 associated with the iris feature information 312 for which the iris authentication was successful, and replies to the requestor with the identified staff ID 311 and attribute information 313 included in the iris authentication result.

[0032] Furthermore, the authentication system 300 determines whether the facial authentication is successful based on the degree of match between facial feature information (query) based on the facial image included in the facial authentication request received via the network N and a plurality of (master) facial feature information 322 in the patient DB 32. If the facial authentication is successful, the authentication system 300 identifies the patient ID 321 (and attribute information) associated with the facial feature information 322 for which the facial authentication was successful, and replies to the request source with the identified patient ID 321 (and attribute information) included in the facial authentication result.

[0033] The medical information system 400 is an information system for managing medical information such as medical records and drug order information. The medical information system 400 includes at least a medical record DB 41 and a drug order DB 42. The medical record DB 41 is a database for managing patient medical record information. The medical record DB 41 manages patient IDs 410 and medical record information 411 in association with each other. Note that the patient ID 410 may be associated with two or more pieces of medical record information 411. The patient ID 410 is information equivalent to the patient ID 321. Therefore, the patient ID 321 for a specific patient U2 is either the same as the patient ID 410 or is information that can uniquely identify the patient ID 410.

[0034] The drug order DB42 is a database that manages one or more pieces of drug registration information 420. The drug registration information 420 is information in which information on drugs to be administered by a doctor to a specific patient is registered in advance. The drug registration information 420 is information that associates, for example, a drug ID 421, medication information 422, a patient ID 423, a registered doctor ID 424, and a change history 425. The drug ID 421 is identification information of the drug. The medication information 422 is information regarding the scheduled administration date and time and dosage of the corresponding drug. The patient ID 423 is identification information of the patient to be administered the corresponding drug. The patient ID 423 is information equivalent to the patient ID 410 described above. The registered doctor ID 424 is identification information of the doctor who registered the medication information 422 to administer the corresponding drug to the corresponding patient. The change history 425 is a change history of the drug ID 421 and medication information 422 registered for the patient corresponding to the patient ID 423. The change history 425 is information that associates, for example, a change date and time 4251, a drug ID 4252, medication information 4253, and a registered doctor ID 4254. The change date and time 4251 is information indicating the date and time (year, month, day, hour, minute, second, etc.) when the drug registration information 420 was changed. The drug ID 4252 is the drug ID 421 before the change. The medication information 4253 is the medication information 422 before the change. The registered doctor ID 4254 is the registered doctor ID 424. Therefore, when the drug registration information 420 is changed, the registered doctor ID 424 becomes identification information of the doctor who changed the drug registration information 420. The change history 425 may also include two or more change histories, including at least the most recent change history.

[0035] The medical information system 400 searches the medical record DB 41 using the patient ID included in the request to acquire medical record information received via the network N as a search key, and returns medical record information 411 found in the search to the request source. The medical information system 400 also searches the drug order DB 42 using the drug ID included in the request to acquire drug registration information received via the network N as a search key, and returns drug registration information 420 found in the search to the request source.

[0036] FIG. 4 is a diagram illustrating the concept of three-point authentication and medication administration performed by a medical practitioner (wearer U1) wearing the AR glasses 100. First, after the wearer U1 puts on the AR glasses 100, the AR glasses 100 perform "(1) wearer authentication" (S10). That is, the AR glasses 100 confirm the medical practice qualification (attributes) through iris authentication with the authentication system 300 (via the authentication support server 200). If wearer authentication is successful, the wearer U1 turns his / her face (gaze) toward the face of the patient U2. Therefore, an external camera (not shown) of the AR glasses 100 captures a facial image of the patient U2 (S21). Then, the authentication support server 200 uses the authentication system 300 to perform identity verification by facial recognition based on the facial image of the patient U2 ("(2) patient authentication") (S22). The wearer U1 also turns his / her face (gaze) toward the vicinity of the information code attached to the medication M. Therefore, the external camera of the AR glasses 100 captures an image of the information code of the drug M (S31). The information code may be, for example, a one-dimensional barcode or a two-dimensional QR (Quick Response) code (registered trademark), but is not limited to these. Then, the authentication support server 200 uses the authentication system 300 to identify drug order information (drug registration information) based on the drug ID analyzed from the captured and read information code, and performs "(3) code authentication" (S32). After steps S10, S22, and S32, the AR glasses 100 display the three-point authentication result (here, "OK") obtained from steps (1), (2), and (3) on a screen for the wearer (not shown) (S40). This allows the wearer U1 to confirm that the three-point authentication was successful, and the wearer U1 then injects the drug M into the patient U2 (S50).

[0037] 5 is a block diagram showing the configuration of the AR glasses 100. The AR glasses 100 include a wearer imaging unit 121, an external imaging unit 122, a sound collection unit 123, a wearer screen 124, a detection unit 130, an acquisition unit 131, a transmission unit 132, and an output control unit 133.

[0038] The wearer photographing unit 121 is a camera that photographs an area including the iris of the eye of the wearer U1, or a circuit or software that controls the camera. The wearer photographing unit 121 outputs an iris image obtained by photographing the iris of the wearer U1 to the acquisition unit 131.

[0039] The external image capturing unit 122 is a camera that captures an image capturing area including the display area (field of view) of the wearer screen 124, or a circuit or software that controls the camera. The external image capturing unit 122 captures at least an image in front of the wearer U1 and outputs the captured image to the acquisition unit 131. For example, the external image capturing unit 122 captures a facial image of the patient U2, an information code of a drug, an information code for a state transition, and the like. The external image capturing unit 122 may record the captured image in an internal storage unit (not shown).

[0040] The sound collection unit 123 is a microphone that collects sounds around the AR glasses 100, or a circuit or software that controls the microphone. The sound collection unit 123 collects the voices uttered by the wearer U1 and the patient U2. Therefore, the sound collection unit 123 collects the voices of the conversation between the wearer U1 and the patient U2, who are medical professionals present near the AR glasses 100, during a medical interview. The sound collection unit 123 may record the collected sound information, or at least the voice information, in a storage unit.

[0041] The wearer's screen 124 is a display that covers at least a part of the field of view of the wearer U1 of the AR glasses 100. The wearer's screen 124 also displays a display image (video) output by the output control unit 133 superimposed on the field of view through which light from the external surrounding space passes.

[0042] The detection unit 130 detects a predetermined action of the wearer U1 via the AR glasses 100. Examples of the detected predetermined action include the following. The detection unit 130 may detect a predetermined voice command by voice recognition of the sound collected by the sound collection unit 123. Alternatively, the detection unit 130 may detect an area indicated by the line of sight of the wearer U1 on the wearer screen 124 using the wearer imaging unit 121 or a line of sight sensor (not shown). For example, when predetermined display information (such as an icon image) is displayed on the wearer screen 124, the detection unit 130 detects that the line of sight of the wearer U1 is directed toward the area of ​​the displayed information. Alternatively, the detection unit 130 may detect a movement (such as a gesture) of the wearer U1's hand or fingers on the wearer screen 124 using the wearer imaging unit 121 or a line of sight sensor (not shown). For example, when the external image capturing unit 122 captures an image of the hands or fingers of the wearer U1, the AR glasses 100 display an image (e.g., a polygon image) corresponding to the hands or fingers of the wearer U1 on the wearer's screen 124. Then, when predetermined display information (e.g., an icon image) is displayed on the wearer's screen 124, the detection unit 130 may detect an operation in which the wearer's fingers press the display information. Alternatively, the detection unit 130 may detect a gesture of the wearer U1's hand or finger image captured by the external image capturing unit 122. Alternatively, the detection unit 130 may detect an information code captured by the external image capturing unit 122. Alternatively, the detection unit 130 may detect a combination or order of the above-mentioned predetermined voice command, a movement (e.g., a gesture) of the wearer U1's hand or fingers, and the captured information code.

[0043] The acquisition unit 131 is an example of the above-mentioned first acquisition unit 11, second acquisition unit 12, and third acquisition unit 13. The acquisition unit 131 acquires an iris image of the wearer U1 from the wearer photographing unit 121, a face image of the patient U2 and information codes of medications and the like from the external photographing unit 122, and audio data of the wearer U1 and the like from the audio collecting unit 123.

[0044] The transmitting unit 132 may transmit an iris authentication request including the iris image of the wearer U1 acquired by the acquiring unit 131 to the authentication support server 200 via the network N. Then, the acquiring unit 131 acquires from the authentication support server 200 a wearer authentication result based on the iris authentication result by the authentication system 300 in the authentication support server 200.

[0045] The transmitting unit 132 may also transmit a face authentication request including the face image of the patient U2 acquired by the acquiring unit 131 to the authentication support server 200 via the network N. The transmitting unit 132 may also transmit the information code of the drug acquired by the acquiring unit 131 to the authentication support server 200 via the network N. Then, the acquiring unit 131 acquires the result of the three-point authentication performed in the authentication support server 200 from the authentication support server 200.

[0046] Furthermore, the transmitting unit 132 transmits a detection notification of the predetermined action detected by the detecting unit 130 to the authentication support server 200 via the network N. Then, the acquiring unit 131 acquires a state transition instruction to the three-point authentication execution state from the authentication support server 200. Note that the transmitting unit 132 may transmit information itself (audio data, action content, etc.) of the predetermined action detected by the detecting unit 130 to the authentication support server 200.

[0047] The output control unit 133 may display the past medical record information of the patient U2 acquired by the acquisition unit 131 on the wearer screen 124. The output control unit 133 may also display transition instruction information to the three-point authentication execution state on the wearer screen 124. The output control unit 133 may also display a patient check field and a medication check field on the wearer screen 124 in response to the transition to the three-point authentication execution state. For example, when the output control unit 133 receives an instruction to transition to the three-point authentication execution state from the authentication support server 200, it may display the patient check field and the medication check field on the wearer screen 124. When the acquisition unit 131 acquires a facial image of the patient U2, the output control unit 133 displays in the patient check field on the wearer screen 124 that the patient has been loaded. When the acquisition unit 131 acquires a medication information code, the output control unit 133 displays in the medication check field on the wearer screen 124 that the medication has been loaded. Furthermore, when the acquisition unit 131 acquires the three-point authentication result, the output control unit 133 displays the three-point authentication result on the wearer screen 124.

[0048] 6 is a block diagram showing the hardware configuration of the AR glasses 100. The AR glasses 100 include a memory 101, a processor 102, a network interface 103, a display 104, an internal camera 105, an external camera 106, and a microphone 107.

[0049] The memory 101 is configured by a combination of volatile memory and non-volatile memory. The volatile memory is, for example, a volatile storage device such as RAM (Random Access Memory), and is a storage area for temporarily holding information when the processor 102 is operating. The non-volatile memory is, for example, a non-volatile storage device such as flash memory. The memory 101 stores at least a computer program that implements part of the processing of the medical record support method for the AR glasses 100 according to the present disclosure.

[0050] The processor 102 is a control device that controls each component of the AR glasses 100. The processor 102 reads and executes software (computer programs) from the memory 101. As a result, the processor 102 realizes the functions of the detection unit 130, the acquisition unit 131, the transmission unit 132, and the output control unit 133. That is, the processor 102 performs part of the processing of the authentication support method according to the present disclosure. The processor 102 may be, for example, a microprocessor, an MPU (Multi Processing Unit), or a CPU (Central Processing Unit). The processor 102 may also include multiple processors.

[0051] The network interface 103 may be used to communicate with a network node. The network interface 103 may include, for example, a network interface card (NIC) conforming to the IEEE 802.3 series. IEEE stands for Institute of Electrical and Electronics Engineers. The network interface 103 may also include a wireless local area network (LAN), a wired LAN, Wi-Fi (registered trademark), Bluetooth (registered trademark), etc.

[0052] The display 104 is a display device that displays information instructed by the processor 102. The display 104 is, for example, a screen such as a liquid crystal display or an organic electro-luminescence (EL) display. In particular, the display 104 transmits external light and corresponds to the above-mentioned wearer screen 124.

[0053] In response to an instruction from the processor 102, the internal camera 105 captures an image of the area including the iris of the eye of the wearer of the AR glasses 100, and outputs the captured iris image to the processor 102. The internal camera 105 corresponds to the wearer capturing unit 121 described above.

[0054] The external camera 106 captures an image of the external surrounding space including the front direction of the AR glasses 100 in response to an instruction from the processor 102, and outputs the captured image to the processor 102. The external camera 106 is, for example, a CCD (Charge Coupled Device) image sensor or a CMOS (Complementary Metal Oxide Semiconductor) sensor. The external camera 106 is one or more image capturing devices. The external camera 106 corresponds to the external image capturing unit 122 described above.

[0055] The microphone 107 is a sound collector that collects sounds around the AR glasses 100.

[0056] 7 is a block diagram showing the configuration of the authentication support server 200. The authentication support server 200 is an information processing device that uses the authentication system 300, the medical information system 400, etc., in accordance with information received from the AR glasses 100 to support three-point authentication performed by a wearer U1 of the AR glasses 100 before administering a predetermined drug M to a patient U2. The authentication support server 200 is an example of the above-mentioned authentication support device 1. The authentication support server 200 includes a storage unit 210, an acquisition unit 221, an authentication control unit 222, a voice recognition unit 223, a state transition unit 224, and an output control unit 225.

[0057] The storage unit 210 includes, for example, a non-volatile storage device such as a hard disk or flash memory, and a memory such as RAM, that is, a volatile storage device. The storage unit 210 stores a program 211 and three-point authentication history information 212. The program 211 is a computer program in which at least a portion of the authentication support processing according to the present disclosure is implemented. The three-point authentication history information 212 is history information of three-point authentication results. The three-point authentication history information 212 is information that associates, for example, a three-point authentication date and time 2121, a three-point authentication result 2122, a wearer authentication result 2123, a patient authentication result 2124, and medication registration information 2125. The three-point authentication date and time 2121 is information indicating the date and time (e.g., year, month, day, hour, minute, second, etc.) when the three-point authentication according to the present disclosure was performed. The three-point authentication result 2122 is information indicating the success or failure of the entire three-point authentication.

[0058] The wearer authentication result 2123 is an authentication result that the wearer U1 of the AR glasses 100 is qualified to perform medical procedures. The wearer authentication result 2123 may include at least information including whether the attribute information 313 of the wearer (staff ID 311) whose iris authentication was successful is qualified to perform medical procedures to administer the drug M, that is, information indicating the success or failure of the wearer authentication. For example, if the iris authentication is successful, the wearer authentication result 2123 may include the staff ID 311 and the attribute information 313, and may include a result indicating whether the attribute information 313 is qualified to perform medical procedures. Note that if only persons qualified to perform medical procedures are registered in the medical institution staff DB 31, the wearer authentication result 2123 may include at least the success or failure of iris authentication, and may include the staff ID 311 if the iris authentication is successful.

[0059] The patient authentication result 2124 is the result of authenticating the face of the patient photographed by the AR glasses 100. The patient authentication result 2124 includes at least the success or failure of face authentication, and may include the patient ID 321 if face authentication is successful.

[0060] The drug registration information 2125 is the drug registration information 420 identified based on the drug information of the drug photographed by the AR glasses 100. In other words, the three-point authentication result 2122 indicates success when the following three conditions are met: the wearer authentication result 2123 indicates successful wearer authentication, the patient authentication result 2124 indicates successful patient authentication, and the patient ID 423 included in the drug registration information 2125 matches the patient ID included in the patient authentication result 2124.

[0061] The acquisition unit 221 is an example of the above-mentioned first acquisition unit 11, second acquisition unit 12, and third acquisition unit 13. The acquisition unit 221 acquires a wearer authentication result indicating whether the wearer U1 is a predetermined medical practitioner, based on the iris authentication result for the iris image of the wearer U1 received from the AR glasses 100. For example, the acquisition unit 221 may acquire, as the wearer authentication result, a determination result indicating whether the wearer U1 is a predetermined medical practitioner, based on the iris authentication result by the authentication control unit 222, which will be described later.

[0062] The acquisition unit 221 also acquires a patient authentication result based on the authentication information received from the AR glasses 100. For example, the acquisition unit 221 may acquire a face authentication result by the authentication control unit 222, which will be described later, as the patient authentication result. Specifically, the acquisition unit 221 may acquire the patient authentication result by controlling patient authentication based on authentication information detected from an image of the patient U2 captured by the AR glasses 100.

[0063] The acquisition unit 221 also acquires drug registration information indicating a correspondence between the drug M identified based on the drug information received from the AR glasses 100 and the patient U2 to be administered. Specifically, the acquisition unit 221 may acquire the drug registration information by identifying the drug registration information corresponding to the drug information detected from the image related to the drug M captured by the AR glasses 100.

[0064] The authentication control unit 222 uses the authentication system 300 to control iris authentication of the iris image of the wearer U1 captured by the wearer photographing unit 121 of the AR glasses 100. Then, the authentication control unit 222 determines whether the wearer U1 is a predetermined medical practitioner based on the iris authentication result. The authentication control unit 222 also uses the authentication system 300 to control face authentication of the face image of the patient U2 captured by the external photographing unit 122 of the AR glasses 100. The authentication control unit 222 also analyzes the drug information code received from the AR glasses 100 to identify the drug ID of the drug information. Then, the authentication control unit 222 identifies and acquires drug registration information 420 in which the identified drug ID is included in the drug ID 421 or the drug ID 4252 from the drug order DB 42 of the medical information system 400.

[0065] Furthermore, the authentication control unit 222 performs three-point authentication based on the acquired wearer authentication result, patient authentication result, and medication registration information. Specifically, the authentication control unit 222 determines that the three-point authentication is successful when it confirms that the wearer authentication result 2123 indicates successful wearer authentication, the patient authentication result 2124 indicates successful patient authentication, and the patient ID 423 included in the medication registration information 2125 matches the patient ID included in the patient authentication result 2124.

[0066] The voice recognition unit 223 converts the voice data into text information by performing voice recognition on the voice data collected by the AR glasses 100. In particular, the voice recognition unit 223 may distinguish speakers and perform voice recognition based on at least one of the volume and the sound collection direction of the sound collection unit 123 of the AR glasses 100.

[0067] When the state transition unit 224 detects a predetermined motion by the wearer U1 via the AR glasses 100, it transitions the operation state of the AR glasses 100 to a three-point authentication execution state in which at least authentication information and medication information can be acquired. Furthermore, when the wearer authentication result indicates that the wearer U1 is a predetermined medical practitioner and the state transition unit 224 detects a predetermined motion by the wearer U1, it transitions the operation state of the AR glasses 100 to the three-point authentication execution state. Furthermore, when the state transition unit 224 detects that the wearer U1 has made a predetermined sound as a predetermined motion, it transitions the operation state of the AR glasses 100 to the three-point authentication execution state.

[0068] The state transition unit 224 transitions to the three-point authentication execution state when detecting, as the predetermined action, a pressing operation by the wearer U1 in response to the transition instruction information to the three-point authentication execution state displayed on the wearer screen 124. For example, the state transition unit 224 may transition to the three-point authentication execution state when detecting, as the predetermined action, that the wearer U1 has made a predetermined sound via the AR glasses 100. Alternatively, the state transition unit 224 may transition to the three-point authentication execution state when detecting, as the predetermined action, a pressing operation by the wearer U1 via the AR glasses 100 in response to the transition instruction information to the three-point authentication execution state displayed on the wearer screen 124. Alternatively, the state transition unit 224 may transition to the three-point authentication execution state when detecting, as the predetermined action, that the wearer U1 has turned his / her gaze via the AR glasses 100 in response to the transition instruction information to the three-point authentication execution state displayed on the wearer screen 124. Alternatively, the state transition unit 224 may transition to the three-point authentication execution state when it detects, as a predetermined action, that the wearer U1 has directed his or her gaze through the AR glasses 100 at an information code for three-point authentication posted at the location where the drug M is administered.

[0069] The output control unit 225 is an example of the above-mentioned output control unit 14. After transitioning to the three-point authentication execution state, if an image related to the patient U2 or the drug M is captured by the AR glasses 100, the output control unit 225 may display that fact on the wearer screen 124.

[0070] Furthermore, the output control unit 225 transmits a three-point authentication result 212 regarding whether or not the wearer U1 can administer the drug M to the patient U2, to the AR glasses 100, based on the wearer authentication result 2123, the patient authentication result 2124, and the drug registration information 2125. That is, the output control unit 225 displays the three-point authentication result 212 on the wearer screen 124 of the AR glasses 100.

[0071] Specifically, when the three-point authentication result 212 indicates that the medical procedure of administering drug M to patient U2 by the wearer U1 of the AR glasses 100 is permitted, the output control unit 225 transmits this information to the AR glasses 100 together with the three-point authentication history information 212. When the three-point authentication result 212 indicates that the medical procedure is not permitted, the output control unit 225 displays the result on the wearer screen 124 of the AR glasses 100, including display information explaining the reason why the medical procedure is not permitted. When the three-point authentication result 212 indicates that the medical procedure is not permitted, the output control unit 225 may operate the AR glasses 100 so that the wearer U1 can perceive this information.

[0072] 8 is a block diagram showing the hardware configuration of the authentication support server 200. The authentication support server 200 includes a memory 501, a processor 202, and a network interface 203.

[0073] The memory 201 stores at least a computer program (e.g., program 211) that implements at least a portion of the processing of the authentication support method of the authentication support server 200 according to the present disclosure. Furthermore, the memory 201 may store three-point authentication history information 212. Other configurations of the memory 201 are the same as those of the memory 101 described above. The processor 202 is a control device that controls each component of the authentication support server 200. The processor 202 reads and executes software (computer programs) from the memory 201. As a result, the processor 202 realizes the functions of an acquisition unit 221, an authentication control unit 222, a voice recognition unit 223, a state transition unit 224, and an output control unit 225. In other words, the processor 202 performs at least a portion of the processing of the authentication support method in the authentication support server 200 according to the present disclosure. Other configurations of the processor 202 are the same as those of the processor 102 described above. The network interface 203 has the same configuration as that of the network interface 103 described above.

[0074] FIG. 9 is a sequence chart showing the flow of authentication support processing when a medical professional wears the AR glasses 100 (normal mode). First, a medical practitioner who intends to administer a drug M to a patient U2 wears the AR glasses 100 to perform three-point authentication before administering the drug M, and becomes the wearer U1. At this time, the AR glasses 100 acquire an iris image of the eyes of the wearer U1 using the wearer photographing unit 121 (S101). Then, the AR glasses 100 transmit an iris authentication request including the acquired iris image of the wearer U1 to the authentication support server 200 via the network N (S102). In response, the authentication support server 200 transmits the received iris authentication request to the authentication system 300 via the network N (S103).

[0075] The authentication system 300 then performs iris authentication of the patient U2 based on the received iris authentication request (S104). Specifically, the authentication system 300 detects the iris area from the iris image included in the iris authentication request and calculates feature amounts for a pattern, such as a marking, that indicates iris characteristics from the detected iris area. The authentication system 300 then extracts a feature vector including a set of the calculated feature amounts as (query) iris feature information. Note that the iris authentication request may include iris feature information extracted by the AR glasses 100 or the authentication support server 200 instead of an iris image.

[0076] The authentication system 300 then compares the query iris feature information with multiple (master) iris feature information 312 in the medical institution staff DB 31 and calculates a matching score indicating the degree of matching as the degree of match. For example, the authentication system 300 may calculate a higher matching score the shorter the distance between the master and query feature vectors. The authentication system 300 then determines that iris authentication has been successful if the degree of match is equal to or greater than a threshold, and determines that iris authentication has failed if the degree of match is less than the threshold. The authentication system 300 includes the iris authentication result in the iris authentication result. If the iris authentication is successful, the authentication system 300 identifies the staff ID 311 and attribute information 313 associated with the iris feature information 312 for which iris authentication was successful. The authentication system 300 then includes the identified staff ID 311 and attribute information 313 in the iris authentication result. The authentication system 300 then returns the iris authentication result to the authentication support server 200 via the network N (S105). For the sake of convenience, it is assumed below that the wearer U1 has successfully passed iris authentication. Therefore, the iris authentication result includes a message indicating that the iris authentication was successful, as well as the employee ID 311 and attribute information 313.

[0077] Then, the authentication support server 200 determines whether the attribute information 313 included in the received iris authentication result is a qualification for medical practice to administer the drug M. In other words, the authentication support server 200 determines that the wearer U1, whose iris authentication was successful, is qualified to perform medical practice, and sets the determination result as the wearer authentication result. For the sake of convenience in the following explanation, it is assumed that the wearer U1 is determined to be qualified to perform medical practice.

[0078] Therefore, the authentication support server 200 generates a wearer authentication result 2123 including the staff ID 311 of the wearer U1 whose iris authentication was successful, and registers the wearer authentication result 2123 in the storage unit 210, including the wearer authentication result 2123 in the three-point authentication history information 212 (S106). Then, the authentication support server 200 transmits the wearer authentication result 2123 to the AR glasses 100 via the network N (S107). In response to receiving the wearer authentication result 2123, the AR glasses 100 operate in normal mode, and make various functions available to the wearer U1.

[0079] Then, in response to receiving the wearer authentication result 2123, the AR glasses 100 transmit a request to acquire medical record information of the patient U2 to the medical information system 400 via the network N (S108). At this time, the acquisition request may include, for example, the patient ID of the patient U2. For example, it is assumed that the wearer U1 already knows the name and patient ID of the patient U2 to whom the drug M is to be administered.

[0080] In response to this, the medical information system 400 searches the medical record DB 41 using the patient ID included in the received acquisition request as a search key, and returns the medical record information 411 found in the search to the AR glasses 100 (S109). Note that the AR glasses 100 may transmit and receive the request to acquire medical record information and the medical record information to and from the medical information system 400 via the authentication support server 200.

[0081] In response to this, the AR glasses 100 receive the medical record information of the patient U2 from the medical information system 400 via the network N, and display the most recent medical record information received on the wearer's screen 124 (S110).

[0082] 10 is a diagram showing a display example of the wearer's screen 5 when the AR glasses 100 are worn (normal mode). For example, the wearer's screen 5 displays the patient U2 and medication M at the bottom of the screen via external light from the AR glasses 100, and displays medical record information 51 and the like at the top of the screen. Note that the display example in normal mode is not limited to this.

[0083] FIG. 11 is a sequence chart showing the flow of authentication support processing at the start of three-point authentication. In normal mode of the AR glasses 100, the wearer U1 performs an action to start three-point authentication. In response to this, the AR glasses 100 detect the action to start three-point authentication by the wearer U1 (S201). Note that multiple patterns that can be taken as the action to start three-point authentication will be described later. The AR glasses 100 send an action detection notification to the authentication support server 200 via the network N (S202). In response to the received action detection notification, the authentication support server 200 sends a state transition instruction to the AR glasses 100 via the network N to transition to a three-point authentication execution state (S203). In response to this, the AR glasses 100 transition to the three-point authentication execution state (S204). For example, the AR glasses 100 display a patient check field and a medication check field on the wearer screen 124. Furthermore, when the AR glasses 100 transition to the three-point authentication execution state, they may be able to acquire a facial image by facial recognition or an information code by code recognition for an image captured by the external image capturing unit 122. When the AR glasses 100 detect an action to start three-point authentication, they may transition to the three-point authentication execution state by internal processing without transmitting or receiving an action detection notification and a state transition instruction to or from the authentication support server 200.

[0084] FIG. 12 is a diagram showing an example of a display on the wearer's screen 5 of the AR glasses 100 after a state transition to the three-point authentication execution state. The wearer's screen 5 shows, for example, an example in which a three-point authentication mode image 52, a patient check field 521, and a medication check field 522 are displayed on the right side. The three-point authentication mode image 52 is an example of a display image indicating that the operation mode of the AR glasses 100 is the three-point authentication execution state. The patient check field 521 is a display field for displaying, when a face image of the patient for patient authentication has been captured, that fact. The medication check field 522 is a display field for displaying, when an information code of a medication has been captured, that fact. At this point, since the state has just transitioned to the three-point authentication execution state, the patient check field 521 and the medication check field 522 are blank. Note that display examples in the three-point authentication execution state are not limited to this.

[0085] After step S204 in FIG. 11, the wearer U1 turns his or her face toward the face of the patient U2. Therefore, the AR glasses 100 capture an image of the face of the patient U2. That is, the AR glasses 100 capture an image of an area including the face of the patient U2 using the external image capturing unit 122, and acquire a facial image of the captured face of the patient U2 (S205). Then, the AR glasses 100 transmit a facial authentication request including the facial image of the patient U2 to the authentication support server 200 via the network N (S206). At this time, the AR glasses 100 may display in the patient check field 521 that the patient has been loaded (S207).

[0086] In response to step S206, the authentication support server 200 transmits the received face authentication request to the authentication system 300 via the network N (S208). In response, the authentication system 300 performs face authentication of the patient U2 based on the received face authentication request (S209). Specifically, the authentication system 300 detects a face area from the face image included in the face authentication request, extracts multiple feature points indicating the person's facial features (eyes, nose, mouth, etc.) from the detected face area, and calculates the distance between each feature point as a feature amount. The authentication system 300 then extracts a feature vector including a set of the calculated multiple feature amounts as (query) face feature information. Note that the face authentication request may include face feature information extracted by the AR glasses 100 or the authentication support server 200 instead of a face image.

[0087] The authentication system 300 then compares the query facial feature information with multiple (master) facial feature information 322 in the patient DB 32 and calculates a matching score indicating the degree of matching as the degree of match. For example, the authentication system 300 may calculate a higher matching score as the distance between the master and query feature vectors is shorter. The authentication system 300 then determines that facial authentication has been successful if the degree of match is equal to or greater than a threshold, and determines that facial authentication has failed if the degree of match is less than the threshold. The authentication system 300 includes the determination result of facial authentication in the facial authentication result. If facial authentication is successful, the authentication system 300 identifies the patient ID 321 associated with the facial feature information 322 whose facial authentication has been successful. The authentication system 300 then includes the identified patient ID 321 in the facial authentication result. The authentication system 300 then returns the facial authentication result to the authentication support server 200 via the network N (S210). For ease of explanation, it is assumed below that patient U2 has been successfully authenticated. Therefore, the face recognition result includes a notification that face recognition was successful and the patient ID.

[0088] The authentication support server 200 then receives the face authentication result from the authentication system 300 via the network N. The authentication support server 200 confirms from the received face authentication result that the face authentication of patient U2 has been successful, and acquires the patient ID included in the face authentication result. The authentication support server 200 then generates a patient authentication result 2124 including the acquired patient ID, and registers the patient authentication result 2124 in the three-point authentication history information 212 in the storage unit 210 (S211).

[0089] The wearer U1 also turns his or her face toward the medicine M. Therefore, the AR glasses 100 capture an image of the information code attached (posted) to the medicine M. That is, the AR glasses 100 capture an image of an area including the information code of the medicine M using the external image capturing unit 122, and acquire an image of the captured information code of the medicine M (S212). Then, the AR glasses 100 transmit a code authentication request for the medicine order information including the information code to the authentication support server 200 via the network N (S213). At this time, the AR glasses 100 may display in the medicine check field 522 that the medicine has been read (S214).

[0090] FIG. 13 is a diagram showing an example of a display on the wearer's screen 5 of the AR glasses 100 after the facial image of patient U2 and the drug information of drug M have been read in. The wearer's screen 5 shows, for example, an example on the right side where the patient check field 521 in FIG. 12 described above has been updated to a patient check field 523, and the drug check field 522 has been updated to a drug check field 524. The patient check field 523 is an example of a display indicating that the patient has been read in. The drug check field 524 is an example of a display indicating that the drug has been read in. Note that display examples are not limited to these.

[0091] In response to step S213 in FIG. 11 , the authentication support server 200 analyzes the information code included in the received code authentication request to identify the drug ID (S215). Then, the authentication support server 200 transmits a request to acquire drug registration information, including the identified drug ID, to the medical information system 400 via the network N (S216). In response to this, the medical information system 400 searches the drug order DB 42 using the drug ID included in the received acquisition request as a search key. At this time, the medical information system 400 searches whether the drug ID used as the search key is included in either the drug ID 421 or the drug ID 4252 in the drug registration information 420 in the drug order DB 42. Then, the medical information system 400 returns the drug registration information 420 found in the search to the authentication support server 200 (S217).

[0092] Thereafter, the authentication support server 200 performs three-point authentication (S218). Specifically, the authentication support server 200 determines whether the patient ID 423 included in the received drug registration information 420 matches the patient ID included in the patient authentication result 2124. Furthermore, the authentication support server 200 determines whether the drug ID identified in step S215 matches either the drug ID 421 or the drug ID 4252 included in the drug registration information 420 received in step S217. If the identified drug ID matches the latest drug ID 421 and the patient IDs match in the above determination, the authentication support server 200 determines that drug authentication (drug code authentication) has been successful. On the other hand, if the identified drug ID does not match the latest drug ID 421, that is, if the identified drug ID matches a past drug ID 4252 in the change history, the authentication support server 200 determines that drug authentication has failed. Therefore, if the wearer authentication result 2123 indicates that the wearer authentication and the drug authentication (drug code authentication) are successful, the authentication support server 200 determines that the three-point authentication is successful and generates a three-point authentication result that includes this fact. On the other hand, in other cases, the authentication support server 200 determines that the three-point authentication is unsuccessful and generates a three-point authentication result that includes this fact. Specifically, the authentication support server 200 adds and registers the three-point authentication date and time 2121, the three-point authentication result 2122, and the drug registration information 2125 to the three-point authentication history information 212 (S221).

[0093] After step S218, the authentication support server 200 transmits the three-point authentication result 2122 to the AR glasses 100 via the network N (S219). In response to this, the AR glasses 100 display the received three-point authentication result 2122 on the wearer screen 124 (S220). Note that the processing order of steps S205 to S211 and steps S212 to S217 may be reversed, or may be executed in parallel.

[0094] Examples of operations for starting three-point authentication according to the present disclosure are given below in Examples 2-1 to 2-4, but the operations for starting three-point authentication are not limited to these.

[0095] <Example 2-1: Voice command> For example, the wearer U1's utterance of a predetermined voice can be regarded as an action to start three-point authentication. FIG. 14 is a diagram showing an example of an action to transition to the three-point authentication execution state. The wearer U1 wearing the AR glasses 100 utters an utterance such as "Start three-point authentication mode" in normal mode (S201a). When the AR glasses 100 recognizes the voice data collected by the sound collection unit 123 as "Start three-point authentication mode," the glasses may detect this as an action to start three-point authentication by the wearer U1. Note that examples of the spoken phrase (voice command for transitioning to the three-point authentication execution state) are not limited to these. In response to this, as described above, the AR glasses 100 transition to the three-point authentication execution state and display the three-point authentication mode image 52, the patient check field 521, and the medication check field 522 on the wearer screen 5.

[0096] <Example 2-2: Pressing the mode switching icon> Furthermore, a pressing operation by the wearer U1 in response to transition instruction information to the three-point authentication execution state displayed on the wearer's screen 5 can be regarded as an operation to start three-point authentication. FIG. 15 is a diagram showing an example of an operation for transitioning to the three-point authentication execution state. First, the AR glasses 100 display a mode switching icon 53 on the wearer's screen 5 in a normal mode menu or the like. The mode switching icon 53 is an example of transition instruction information to the three-point authentication execution state. The AR glasses 100 may also display the mode switching icon 53 on the wearer's screen 5 in response to an operation by the wearer U1 or the like. In this state (normal mode), the wearer U1 wearing the AR glasses 100 moves his / her finger so as to press the mode switching icon 53 on the wearer's screen 5 (S201b). Specifically, when the hand, including the wearer U1's finger, is captured within the imaging range of the external imaging unit 122, the AR glasses 100 display a finger movement image 54 of the wearer U1 on the wearer's screen 5. Then, the wearer U1 moves his / her hand and fingers so as to move the finger movement image 54 to a position where it overlaps with the mode switching icon 53. Then, for example, the wearer U1 moves his / her hand and fingers so that his / her finger movement image 54 presses the mode switching icon 53. In response, the AR glasses 100 detect a pressing operation by the wearer U1 on the mode switching icon 53 by analyzing the image captured by the external imaging unit 122. In this case, the AR glasses 100 may detect this as an action to start three-point authentication by the wearer U1. In response, as described above, the AR glasses 100 transition to the three-point authentication execution state and display the three-point authentication mode image 52, the patient check field 521, and the medication check field 522 on the wearer screen 5. Note that the pressing operation of the mode switching icon is not limited to this. The action to start three-point authentication may also be a gesture by the wearer U1. For example, the AR glasses 100 may detect an action of the wearer U1 bringing two fingers together as an action to start three-point authentication.

[0097] <Example 2-3: Eye contact on mode switching icon + voice command> Furthermore, the start of three-point authentication can be achieved when the wearer U1 directs their gaze via the AR glasses 100 in response to transition instruction information to the three-point authentication execution state displayed on the wearer's screen 5 and then utters a predetermined sound. FIG. 16 is a diagram showing an example of an operation for transitioning to the three-point authentication execution state. First, the AR glasses 100 display the above-described mode switching icon 53 on the wearer's screen 5 in a normal mode menu or the like. In this state (normal mode), the wearer U1 wearing the AR glasses 100 directs their gaze toward the mode switching icon 53 (on the wearer's screen 5) for a predetermined time (S201c-1). The predetermined time may be, for example, within a few seconds. At this time, the AR glasses 100 detect, via the wearer's image capturing unit 121, that the wearer U1's gaze has been directed toward the mode switching icon 53 on the wearer's screen 5 for the predetermined time. This state may also be expressed as the wearer U1 locking the mode switching icon 53. In this state, the wearer U1 utters an utterance such as "Start three-point authentication mode" (S201c-2). When S201c-2 is performed after step S201c-1, the AR glasses 100 may detect this as an action to start three-point authentication by the wearer U1. In response to this, as described above, the AR glasses 100 transition to the three-point authentication execution state and display the three-point authentication mode image 52, the patient check field 521, and the medication check field 522 on the wearer screen 5. Note that when the wearer U1's line of sight locks onto the mode switching icon 53 (i.e., only step S201c-1), the AR glasses 100 may also detect this as an action to start three-point authentication by the wearer U1. However, by performing S201c-2 after step S201c-1, it is possible to prevent the wearer U1 from accidentally transitioning to the three-point authentication execution state when the wearer U1 unintentionally directs his or her gaze toward the mode switching icon 53. Furthermore, after the wearer U1 has erroneously transitioned to the three-point authentication execution state, it is possible to reduce the effort required for the wearer U1 to perform an operation (for example, a cancel operation) to return from the three-point authentication execution state to the normal mode.

[0098] <Example 2-4: Photographing the information code for three-point authentication posted at the drug administration site> Furthermore, the start of three-point authentication can be determined as the wearer U1 directing their gaze via the AR glasses 100 to an information code for three-point authentication posted at the administration location of the drug M. In this case, the AR glasses 100 may analyze the information code captured by the external image capturing unit 122 and detect, as the start of three-point authentication, that the wearer U1 has directed their gaze to the information code for three-point authentication. In response to this, as described above, the AR glasses 100 transition to the three-point authentication execution state and display the three-point authentication mode image 52, the patient check field 521, and the drug check field 522 on the wearer screen 5.

[0099] FIG. 17 is a diagram showing an example of a display on the wearer's screen 5 of the AR glasses 100 when three-point authentication is successful. The wearer's screen 5 includes a three-point authentication result 55. The three-point authentication result 55 is an example of display information indicating that three-point authentication was successful. As a result, the wearer U1 of the AR glasses 100 can visually recognize from the three-point authentication result 55 that he or she is able to perform the medical procedure of administering medication M to the patient U2 in front of him or her. This allows the wearer U1 to perform three-point authentication without using both hands, reducing the complexity of three-point authentication before administering medication to a patient. This makes it less likely that three-point authentication will be postponed, even in an emergency, thereby reducing the risk of a medical accident.

[0100] FIG. 18 is a diagram showing an example of a display on the wearer's screen 5 of the AR glasses 100 when three-point authentication has failed. The wearer's screen 5 includes a three-point authentication result 56. The three-point authentication result 56 is an example of display information indicating that three-point authentication has failed. The example of the three-point authentication result 56 indicates that the drug ID identified from the information code attached to the drug M is outdated, and a message is displayed to prohibit administration of the drug M to the patient U2. That is, this example shows a case in which the drug ID identified from the information code of the drug M photographed by the AR glasses 100 is different from the drug ID 421 in the drug registration information 420 searched in the medical information system 400 and matches the drug ID 4252 in the change history 425. As a result, the wearer U1 of the AR glasses 100 can visually recognize from the three-point authentication result 56 that he or she should not perform the medical procedure of administering the drug M to the patient U2 in front of him or her. The three-point authentication result 212 is also recorded in the storage unit 210 of the authentication support server 200. Therefore, it is possible to prevent the wearer U1 from maliciously administering the drug M. In addition to the three-point authentication result 56, the wearer authentication result 2123 may also indicate that the iris authentication of the wearer U1 has failed or that the wearer U1 is not qualified to administer the drug M. In this case, in addition to being displayed on the wearer screen 5, the wearer authentication result 2123 is also recorded in the storage unit 210 of the authentication support server 200, so the wearer U1 can also refrain from moral problems such as impersonation by an unqualified person through the misuse of an employee ID card, etc.

[0101] As such, originally, three-point authentication when administering medication to a patient required holding a dedicated terminal and performing operations such as reading an information code, which was cumbersome and required hands to be occupied. As a result, there were cases where the confirmation results of three-point authentication were recorded after the fact, which actually increased the risk of medical accidents. In particular, in emergencies, three-point authentication was often postponed, which increased the risk of medical accidents.

[0102] In contrast, with the authentication support method according to the present disclosure, a wearer (prospective medical practitioner) wearing the AR glasses 100 can perform three-point authentication without having to use their hands for the three-point authentication, and the results of the three-point authentication can be visually confirmed. Therefore, the prospective medical practitioner can perform three-point authentication while verbally interviewing the patient and preparing to administer medication. Particularly in an emergency, the prospective medical practitioner can devote both hands to providing medical care to the patient. This reduces the complexity of three-point authentication and the possibility of the three-point authentication being recorded after the fact, making it possible to prevent medical accidents through three-point authentication. This reduces the risk of medical accidents. It also serves as a measure to prevent moral issues, such as impersonating a medical practitioner by misusing a staff ID card.

[0103] <Embodiment 3> In the third embodiment, patient authentication in three-point authentication is performed as code authentication. FIG. 19 is a diagram for explaining the concept of three-point authentication performed by a medical practitioner (wearer U1) wearing the AR glasses 100. The following mainly explains the differences from FIG. 4 described above. Note that the authentication system 300b can eliminate the need for facial feature information 322 in the patient DB 32 of the authentication system 300 shown in FIG. 3 described above. Instead, it is assumed that patient U2 wears a wristband on his or her wrist on which an information code uniquely corresponding to his or her own patient ID 321 is displayed.

[0104] First, as in FIG. 4, after the wearer U1 puts on the AR glasses 100, the AR glasses 100 perform "(1) wearer authentication" (S10). If the wearer authentication is successful, the wearer U1 turns his / her face (gaze) toward the wrist of the patient U2. Therefore, an external camera (not shown) of the AR glasses 100 captures an image of the information code attached to the wrist of the patient U2 (S21b). Then, the authentication support server 200 uses the authentication system 300 to perform identity verification by code authentication based on the captured information code ("(2B) patient authentication") (S22b). Also, as in FIG. 4, the AR glasses 100 perform "(3) code authentication" (S31 and S32). After steps S10, S22b, and S32, the AR glasses 100 display the three-point authentication results (here, "OK") obtained from (1), (2B), and (3) on a screen for the wearer (not shown) (S40b). This allows the wearer U1 to confirm that the three-point authentication has been successful, and then injects the drug M into the patient U2 (S50).

[0105] In this way, the third embodiment can also achieve the same effects as the second embodiment described above.

[0106] <Embodiment 4> The authentication support device according to the fourth embodiment is a glasses-type wearable terminal incorporating the configuration and functions of the authentication support server 200 described above. FIG. 20 is a block diagram showing the configuration of AR glasses 100c. Compared to the AR glasses 100c shown in FIG. 5, a storage unit 110, a state transition unit 134, a voice recognition unit 135, and an authentication control unit 136 have been added, and an acquisition unit 131c, a transmission unit 132c, and an output control unit 133c have been modified. The other configurations, authentication system 300, and medical information system 400 are the same as those of the second embodiment. Therefore, the following description will omit the configuration common to the AR glasses 100 described above. The hardware configuration of the AR glasses 100c is the same as that shown in FIG. 6 described above.

[0107] The storage unit 110 corresponds to the memory 101 in FIG. 6 described above. The program 111 is a modified version of the computer program stored in the memory 101 described above. The program 111 is a computer program in which the processing of the authentication support method according to the present disclosure is implemented. The three-point authentication history information 112 is the same as the three-point authentication history information 212 in FIG. 7 described above. Therefore, the three-point authentication date and time 1121, the three-point authentication result 1122, the wearer authentication result 1123, the patient authentication result 1124, and the medication registration information 1125 included in the three-point authentication history information 112 correspond to the three-point authentication date and time 2121, the three-point authentication result 2122, the wearer authentication result 2123, the patient authentication result 2124, and the medication registration information 2125, respectively.

[0108] The acquisition unit 131c is an example of the first acquisition unit 11, the second acquisition unit 12, and the third acquisition unit 13 described above. The transmission unit 132c transmits an iris authentication request and a face authentication request to the authentication system 300 via the network N. The acquisition unit 131c then acquires the wearer authentication result and the face authentication result from the authentication system 300. The transmission unit 132c also transmits a request to acquire medical record information of the patient U2 to the medical information system 400 via the network N. The acquisition unit 131c then acquires the medical record information of the patient U2 from the medical information system 400 via the network N. The acquisition unit 131c also acquires the drug registration information by identifying drug registration information corresponding to drug information detected from an image related to the drug M captured by the wearer photographing unit 121. Specifically, the transmission unit 132c analyzes the information code to identify a drug ID, and transmits a request to acquire drug registration information including the identified drug ID to the medical information system 400 via the network N. Therefore, the acquiring unit 131c and the transmitting unit 132c may implement part of the functions of the authentication control unit 222 described above.

[0109] The voice recognition unit 135 has the same function as the voice recognition unit 223 described above.

[0110] The state transition unit 134 transitions the operation state of the AR glasses 100 to a three-point authentication execution state that enables acquisition of at least authentication information and drug information when the detection unit 130 detects a predetermined action by the wearer U1 via the AR glasses 100. Other functions of the state transition unit 134 are similar to those of the state transition unit 224 described above.

[0111] The authentication control unit 136 performs three-point authentication based on the acquired wearer authentication result, patient authentication result, and medication registration information.

[0112] After the state transition unit 134 transitions to the three-point authentication execution state, the output control unit 133c displays a patient check field and a medication check field on the wearer screen 124. In addition, the output control unit 133c functions in the same way as the output control unit 133 described above.

[0113] In this way, the third embodiment can also achieve the same effects as the second embodiment described above.

[0114] <Other embodiments> The authentication support device described above may detect a person area including a person's body and a drug area including a drug information code from an image captured by the AR glasses 100 after transitioning to the three-point authentication execution state. In this case, the authentication support device may further include a fourth acquisition means for acquiring patient biometric information from the person area as authentication information and analyzing the information code included in the drug area to acquire the information as drug information. In this way, by acquiring the authentication information and drug information from one image after transitioning to the three-point authentication execution state rather than before transitioning to the three-point authentication execution state, excessive authentication can be prevented.

[0115] The authentication support server 200 or the AR glasses 100c described above may incorporate some or all of the configurations and functions of the authentication system 300 and the medical information system 400.

[0116] Although the present disclosure has been described above with reference to the embodiments, the present disclosure is not limited to the above-described embodiments. Various modifications that can be understood by those skilled in the art can be made to the configuration and details of the present disclosure within the scope of the present disclosure. Furthermore, each embodiment can be combined with other embodiments as appropriate.

[0117] Each drawing is merely an example for describing one or more embodiments. Each drawing may relate not only to one particular embodiment, but also to one or more other embodiments. As will be understood by those skilled in the art, various features or steps described with reference to any one drawing can be combined with features or steps shown in one or more other drawings to create, for example, an embodiment not explicitly shown or described. Not all features or steps shown in any one drawing are necessary to describe an exemplary embodiment, and some features or steps may be omitted. The order of steps described in any drawing may be changed as appropriate.

[0118] A part or all of the above-described embodiments can be described as, but not limited to, the following supplementary notes. (Appendix A1) a first acquisition means for acquiring a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on an iris authentication result of the wearer while wearing the glasses-type wearable terminal; a second acquisition means for acquiring a patient authentication result based on the patient's authentication information photographed by the glasses-type wearable terminal; a third acquisition means for acquiring drug registration information indicating a correspondence between a drug identified based on drug information of the drug photographed by the glasses-type wearable terminal and a patient to be administered the drug; an output control means for displaying a three-point authentication result regarding whether or not the wearer can administer the drug to the patient based on the wearer authentication result, the patient authentication result, and the drug registration information on a screen for the wearer of the eyeglass-type wearable terminal; An authentication support device comprising: (Appendix A2) The device further includes a state transition means for transitioning the operation state of the eyeglass-type wearable terminal to a three-point authentication execution state in which at least the authentication information and the medication information can be acquired when a predetermined action by the wearer via the eyeglass-type wearable terminal is detected. 10. The authentication support device according to claim 1. (Appendix A3) The state transition means transitions to the three-point authentication execution state when the wearer authentication result indicates that the wearer is a predetermined medical practitioner and a predetermined movement by the wearer is detected. 10. The authentication support device according to claim 9, wherein the authentication support device is a (Appendix A4) The output control means After the transition to the three-point authentication execution state, if an image relating to the patient or the medicine is captured by the eyeglass-type wearable terminal, the image is displayed on the wearer's screen. 10. The authentication support device according to claim 9, wherein the authentication support device is a device for supporting authentication of a plurality of authentication targets. (Appendix A5) When the three-point authentication result indicates that the medical treatment is not permitted, the output control means displays, on a screen for the wearer of the eyeglass-type wearable terminal, display information explaining the reason for the medical treatment being not permitted. An authentication support device according to any one of appendices A1 to A4. (Appendix A6) When the three-point authentication result indicates that the medical treatment has not been performed, the output control means operates the glasses-type wearable terminal so that the wearer can perceive this fact. An authentication support device according to any one of appendices A1 to A5. (Appendix A7) The authentication support device is built into the eyeglass-type wearable terminal. An authentication support device according to any one of appendices A1 to A6. (Appendix A8) The state transition means transitions to the three-point authentication execution state when detecting that the wearer has made a predetermined sound as the predetermined action. An authentication support device according to any one of appendices A2 to A4. (Appendix A9) The state transition means transitions to the three-point authentication execution state when detecting, as the predetermined action, a pressing operation by the wearer in response to transition instruction information to the three-point authentication execution state displayed on the wearer screen. An authentication support device according to any one of appendices A2 to A4. (Appendix A10) The state transition means transitions to the three-point authentication execution state when detecting, as the predetermined action, that the wearer directs their gaze via the glasses-type wearable terminal and then utters a predetermined sound in response to transition instruction information to the three-point authentication execution state displayed on the wearer screen. An authentication support device according to any one of appendices A2 to A4. (Appendix A11) The state transition means transitions to the three-point authentication execution state when detecting, as the predetermined action, that the wearer directs their gaze via the eyeglass-type wearable device to an information code for three-point authentication posted at the medication administration location. An authentication support device according to any one of appendices A2 to A4. (Appendix A12) and a fourth acquisition means for acquiring, when a person area including the person's body and a medicine area including an information code of the medicine are detected from an image captured by the glasses-type wearable terminal after transition to the three-point authentication execution state, biometric information of the patient from the person area as the authentication information and analyzing the information code included in the medicine area to acquire the biometric information as the medicine information. An authentication support device according to any one of appendices A2 to A4 or A8 to A11. (Appendix A13) an authentication control means for controlling iris authentication of an iris image of the wearer captured by a wearer's camera of the eyeglass-type wearable device, and determining whether the wearer is a predetermined medical practitioner based on the iris authentication result; The first acquisition means acquires the determination result by the authentication control means as the wearer authentication result. An authentication support device according to any one of appendices A1 to A12. (Appendix B1) A glasses-type wearable device, an authentication support device; The glasses-type wearable terminal includes: An iris image of the wearer while wearing the device, the photographed patient authentication information, and the photographed medication information are transmitted to the authentication support device; the authentication assistance device, acquiring a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on an iris authentication result for the iris image received from the glasses-type wearable terminal; acquiring a patient authentication result based on the authentication information received from the glasses-type wearable terminal; acquiring drug registration information indicating a correspondence between the drug identified based on the drug information received from the eyeglass-type wearable terminal and a patient to whom the drug is to be administered; transmitting a three-point authentication result regarding whether or not the wearer can administer the medication to the patient based on the wearer authentication result, the patient authentication result, and the medication registration information to the glasses-type wearable terminal; The glasses-type wearable terminal includes: The three-point authentication result received from the authentication support device is displayed on a screen for the wearer. Authentication support system. (Appendix C1) The computer Based on the iris authentication result of the wearer while wearing the eyeglass-type wearable device, a wearer authentication result is obtained as to whether the wearer is a predetermined medical practitioner; acquiring a patient authentication result based on the patient's authentication information photographed by the glasses-type wearable terminal; Acquire drug registration information indicating a correspondence between the drug identified based on the drug information of the drug photographed by the eyeglass-type wearable terminal and the patient to whom the drug is to be administered; A three-point authentication result regarding whether or not the wearer can administer the drug to the patient is displayed on a screen for the wearer of the eyeglass-type wearable terminal based on the wearer authentication result, the patient authentication result, and the drug registration information. Authentication assistance methods. (Appendix D1) a first acquisition process for acquiring a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on the iris authentication result of the wearer while wearing the glasses-type wearable terminal; a second acquisition process for acquiring a patient authentication result based on the patient's authentication information photographed by the glasses-type wearable terminal; a third acquisition process for acquiring drug registration information indicating a correspondence between the drug identified based on the drug information of the drug photographed by the glasses-type wearable terminal and the patient to whom the drug is to be administered; an output control process for displaying a three-point authentication result regarding whether or not the wearer can administer the medication to the patient based on the wearer authentication result, the patient authentication result, and the medication registration information on a wearer screen of the eyeglass-type wearable terminal; An authentication support program that causes a computer to execute the above.

[0119] Some or all of the elements (e.g., configurations and functions) described in Appendix A2 to Appendix A13 that are dependent on Appendix A1 {e.g., device} may also be dependent on Appendix B1 {e.g., system}, Appendix C1 {e.g., method}, and Appendix D1 {e.g., program} in the same dependency relationship as Appendix A2 to Appendix A13. Some or all of the elements described in any appendix may be applied to various hardware, software, recording means for recording software, systems, and methods. [Explanation of symbols]

[0120] 1. Authentication support device 11 First Acquisition Section 12 Second Acquisition Section 13 Third Acquisition Section 14 Output control section 1000 Authentication Support System U1 wearer U2 patient M drug N Network 100 AR Glasses 100a AR Glasses 200 Authentication Support Server 300 Authentication System 31 Medical institution staff database 311 Employee ID 312 Iris feature information 313 Attribute information 32 Patient DB 321 Patient ID 322 facial feature information 400 Medical Information Systems 41 Medical Record DB 410 Patient ID 411 Medical Record Information 42 Drug Order DB 420 Drug Registration Information 421 Drug ID 422 Medication Information 423 Patient ID 424 Registered Physician ID 425 Changelog 4251 Change Date 4252 Drug ID 4253 Medication Information 4254 Registered Physician ID 110 Storage section 111 Program 112 Three-point authentication history information 1121 Three-point authentication date and time 1122 Three-point authentication result 1123 Wearer authentication result 1124 Patient authentication results 1125 Drug Registration Information 121 Wearer Photography Department 122 External Photography Department 123 Sound pickup section 124 Wearer's Screen 130 Detector 131 Acquisition Department 131c Acquisition Department 132 Transmitter 132c transmitter 133 Output control section 133c Output control section 134 State Transition Section 135 Voice Recognition Unit 136 Authentication control section 101 Memory 102 processors 103 Network Interface 104 Display 105 Internal Camera 106 External Camera 107 Mike 210 Storage section 211 Program 212 Three-point authentication history information 2121 Three-point authentication date and time 2122 Three-point authentication result 2123 Wearer authentication result 2124 Patient authentication results 2125 Drug Registration Information 221 Acquisition Department 222 Authentication control section 223 Voice Recognition Unit 224 State Transition Section 225 Output control section 201 Memory 202 processors 203 Network Interface 5 Wearer screen 51 Medical Record Information 52 Three-point authentication mode image 521 Patient Checklist 522 Medication Check Column 523 Patient Checklist 524 Medication Checklist 53 Mode switch icon 54 Finger Movement Images 55 Three-point authentication results 56 Three-point authentication results

Claims

1. a first acquisition means for acquiring a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on an iris authentication result of the wearer while wearing the glasses-type wearable terminal; a second acquisition means for acquiring a patient authentication result based on the patient's authentication information photographed by the glasses-type wearable terminal; a third acquisition means for acquiring drug registration information indicating a correspondence between a drug identified based on drug information of the drug photographed by the glasses-type wearable terminal and a patient to be administered the drug; an output control means for displaying a three-point authentication result regarding whether or not the wearer can administer the drug to the patient based on the wearer authentication result, the patient authentication result, and the drug registration information on a screen for the wearer of the eyeglass-type wearable terminal; An authentication support device comprising:

2. The device further includes a state transition means for transitioning the operation state of the eyeglass-type wearable terminal to a three-point authentication execution state in which at least the authentication information and the medication information can be acquired when a predetermined action by the wearer via the eyeglass-type wearable terminal is detected. The authentication support device according to claim 1 .

3. The state transition means transitions to the three-point authentication execution state when the wearer authentication result indicates that the wearer is a predetermined medical practitioner and a predetermined movement by the wearer is detected. The authentication support device according to claim 2 .

4. The output control means After the transition to the three-point authentication execution state, if an image relating to the patient or the medicine is captured by the eyeglass-type wearable terminal, the image is displayed on the wearer's screen.

4. The authentication support device according to claim 2 or 3.

5. When the three-point authentication result indicates that the medical treatment is not permitted, the output control means displays, on a screen for the wearer of the eyeglass-type wearable terminal, display information explaining the reason for the medical treatment being not permitted.

3. The authentication support device according to claim 1.

6. When the three-point authentication result indicates that the medical treatment is not performed, the output control means operates the glasses-type wearable terminal so that the wearer can perceive this fact.

3. The authentication support device according to claim 1.

7. The authentication support device is built into the eyeglass-type wearable terminal.

3. The authentication support device according to claim 1.

8. A glasses-type wearable device, an authentication support device; The glasses-type wearable terminal includes: An iris image of the wearer while wearing the device, the photographed patient authentication information, and the photographed medication information are transmitted to the authentication support device; the authentication assistance device, acquiring a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on an iris authentication result for the iris image received from the glasses-type wearable terminal; acquiring a patient authentication result based on the authentication information received from the glasses-type wearable terminal; acquiring drug registration information indicating a correspondence relationship between the drug identified based on the drug information received from the eyeglass-type wearable terminal and a patient to whom the drug is to be administered; transmitting a three-point authentication result regarding whether or not the wearer can administer the medication to the patient based on the wearer authentication result, the patient authentication result, and the medication registration information to the glasses-type wearable terminal; The glasses-type wearable terminal includes: The three-point authentication result received from the authentication support device is displayed on a screen for the wearer. Authentication support system.

9. The computer Based on the iris authentication result of the wearer while wearing the eyeglass-type wearable device, a wearer authentication result is obtained as to whether the wearer is a predetermined medical practitioner; acquiring a patient authentication result based on the patient's authentication information photographed by the glasses-type wearable terminal; Acquire drug registration information indicating a correspondence between the drug identified based on the drug information of the drug photographed by the eyeglass-type wearable terminal and the patient to whom the drug is to be administered; A three-point authentication result regarding whether or not the wearer can administer the drug to the patient is displayed on a screen for the wearer of the eyeglass-type wearable terminal based on the wearer authentication result, the patient authentication result, and the drug registration information. Authentication assistance methods.

10. a first acquisition process for acquiring a wearer authentication result indicating whether the wearer is a predetermined medical practitioner based on an iris authentication result of the wearer while wearing the glasses-type wearable terminal; a second acquisition process for acquiring a patient authentication result based on authentication information of the patient photographed by the glasses-type wearable terminal; a third acquisition process for acquiring drug registration information indicating a correspondence between a drug identified based on drug information of the drug photographed by the glasses-type wearable terminal and a patient to be administered the drug; an output control process for displaying a three-point authentication result regarding whether or not the wearer can administer the medication to the patient based on the wearer authentication result, the patient authentication result, and the medication registration information on a wearer screen of the eyeglass-type wearable terminal; An authentication support program that causes a computer to execute the above.

Images